Non-diabetic microalbuminuria,endothelial dysfunction and cardiovascular disease

Abstract

Subclinical increases in albuminuria (microalbuminuria) predict morbid events, but the reasons for that are still not understood in full. This paper reviews the existing evidence regarding the relationships of non-diabetic microalbuminuria and cardiovascular disease, the underlying assumption being that endothelial dysfunction contributes both to atherosclerotic macrovascular disease and renal microvascular disease of which albuminuria is a marker. Much data support that concept, and suggest a preferential link with endothelial activation in response to acute and subclinical inflammatory stimulation, although further studies are needed to establish the exact cause-effect mechanisms. Epidemiological studies also show associations with cardiovascular events, and some recent prospective results also indicate the power of micro-albuminuria to predict risk independently from conventional atherogenic factors. Thus, micro-albuminuria might be considered as an integrated marker of cardiovascular risk sensitive to systemic vascular status in addition to other parameters such as blood pressure levels, glucose metabolism, smoking habits, a profile rather unique among the prognostic predictors available to stratify risk in hypertensive patients.

Keywords

albuminuria cardiovascular risk factors essential hypertension inflammation vascular endothelium

References

Parving HH , Jensen HA , Mogensen HA , Evrin PE. Increased urinary albumin excretion rate in benign essential hypertension. Lancet 1974; i: 1190-1193.

Levitt JI. The prognostic significance of proteinuria in young college students. Ann Intern Med 1967; 66: 685-696.

Feldt-Rasmussen B. Microalbuminuria, endothelial dysfunction and cardiovascular risk. Diabetes Metab 2000; 26 (suppl 4): 64-66.

Pedrinelli R. Microalbuminuria in hypertension. Nephron 1996; 73: 499-505.

Viberti GC , Hill RD , Jarrett RJ , Argyropoulos A , Mahmud U , Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1982; 1: 1430-1432.

Mogensen CE , Vestbo E , Poulsen PL et al. Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion. Diabetes Care 1995; 18: 572-581.

Ross R. Atherosclerosis: the role of endothelial injury, smooth muscle proliferation and platelet factors. Triangle 1976; 15:45-51.

Cines DB , Pollak ES , Buck CA et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91: 3527-3561.

Stehouwer CDA , Lambert J , Donker AJM , van Hinsbergh VWM. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 1997; 34:55-68.

10.

Rossing P , Hougaard P , Borch-Johnsen K , Parving HH. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ 1996; 313: 779-784.

11.

Dinneen SF , Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997; 157: 1413-1418.

12.

Pedrinelli R , Giampietro O , Carmassi F et al. Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 1994; 344: 14-18.

13.

Mannucci PM.

Von Willebrand factor: a marker of endothelial damage?

Arterioscler Thromb Vasc Biol 1998; 18: 1359-1362.

14.

Thompson SG , Kienast J , Pyke SDM , Haverkate F , van de Loo JCW , for the European Concerted Action On Thrombosis, and Disabilities Angina Pectoris Study Group . Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635-641.

15.

Blann AD , Taberner DA.

A reliable marker of endothelial cell dysfunction: does it exist?

Br J Haematol 1995; 90: 244-248.

16.

Kario K , Matsuo T , Kobayashi H et al. Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria. Arterioscler Thromb Vasc Biol 1996; 16: 455-461.

17.

Ferri C , Bellini C , Desideri G et al. Clustering of endothelial markers of vascular damage in human salt-sensitive hypertension: influence of dietary sodium load and depletion. Hypertension 1998; 32: 862-868.

18.

Tsang GM , Allen S , Pagano D , Wong C , Graham TR , Bonser RS. Von Willebrand factor and urinary albumin excretion are possible indicators of endothelial dysfunction in cardiopulmonary bypass. Eur J Cardiothorac Surg 1998; 13: 385-391.

19.

Cottone S , Vadala A , Mangano MT et al. Endothelium-derived factors in microalbuminuric and nonmicroalbuminuric essential hypertensives. Am J Hypertens 2000; 13: 172-176.

20.

Clausen P , Feldt-Rasmussen B , Jensen G , Jensen JS. Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study. Clin Sci (Colch) 1999; 97:37-43.

21.

Clausen P , Jensen JS , Jensen G , Borch-Johnsen K , Feldt-Rasmussen B. Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects. Circulation 2001; 103: 1869-1874.

22.

Taddei S , Virdis A , Mattei P et al. Lack of correlation between micro-albuminuria and endothelial function in essential hypertensive patients. J Hypertens 1995; 13: 1003-1008.

23.

Jensen JS , Myrup B , Borch-Jensen K , Jensen G , Jensen T , Feldt-Rasmussen B. Aspects of haemostatic function in healthy subjects with microalbuminuria - a potential atherosclerotic risk factor. Thromb Res 1995; 77: 423-430.

24.

Vane JR , Angaard EE , Botting RM. Mechanisms of disease: regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36.

25.

Lentsch AB , Ward PA. Regulation of inflammatory vascular damage. J Pathol 2000; 190: 343-348.

26.

Gosling P , Hughes EA , Reynolds TM , Fox JP. Microalbuminuria is an early response following acute myocardial infarction. Eur Heart J 1991; 12: 508-513.

27.

Berton G , Citro T , Palmieri R , Petucco S , De Toni R , Palatini P. Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality. Circulation 1997; 96: 3338-3345.

28.

Whicher J , Biasucci L , Rifai N. Inflammation, the acute phase response and atherosclerosis. Clin Chem Lab Med 1999; 37: 495-503.

29.

Morrow DA , Ridker PM. C-reactive protein, inflammation, and coronary risk. Med Clin North Am 2000; 84: 149-161.

30.

Berton G , Cordiano R , Mbaso S , De Toni R , Mormino P , Palatini P. Prognostic significance of hypertension and albuminuria for early mortality after acute myocardial infarction. J Hypertens 1998; 16: 525-530.

31.

Hickey NC , Gosling P , Baar S , Shearman CP , Simms MH. Effect of surgery on the systemic inflammatory response to intermittent claudication. Br J Surg 1990; 77: 1121-1124.

32.

Hickey NC , Hudlicka O , Gosling P , Shearman CP , Simms MH. Intermittent claudication incites systemic neutrophil activation and increased vascular permeability. Br J Surg 1993; 80: 181-184.

33.

Beamer NB , Coull BM , Clark WM , Briley DP , Wynn M , Sexton G. Persistent inflammatory response in stroke survivors. Neurology 1998; 50: 1722-1728.

34.

Beamer NB , Coull BM , Clark WM , Wynn M. Microalbuminuria in ischemic stroke. Arch Neurol 1999; 56: 699-702.

35.

Kaysen GA. Biological basis of hypoalbuminemia in ESRD. J Am Soc Nephrol 1998; 9: 2368-2376.

36.

Luke DR , Sarnoski TP , Dennis S. Incidence of microalbuminuria in ambulatory patients with acquired immunodeficiency syndrome. Clin Nephrol 1992; 38:69-74.

37.

Pedersen LM , Nordin H , Svensson B , Bliddal H. Microalbuminuria in patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54: 189-192.

38.

Mahmud N , McDonald GS , Kelleher D , Weir DG. Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease. Gut 1996; 38:99-103.

39.

Pallister I , Gosling P , Alpar K , Bradley S. Prediction of post-traumatic adult respiratory distress syndrome by albumin excretion rate eight hours after admission. J Trauma 1997; 42: 1056-1061.

40.

Gosling P. Microalbuminuria and cardiovascular risk: a word of caution. J Hum Hypertens 1998; 12: 211-213.

41.

Montalescot G , Collet JP , Choussat R , Thomas D. Fibrinogen as a risk factor for coronary heart disease. Eur Heart J 1998; 19 (suppl H) H11-H17.

42.

Pedrinelli R , Dell’Omo G , Barchielli A et al. Fibrinogen and mortality in chronic critical limb ischemia. J Intern Med 1999; 245:75-81.

43.

Ridker PM , Glynn RJ , Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 1998; 97: 2007-2011.

44.

Festa A , D’Agostino R , Howard G , Mykkanen L , Tracy RP , Haffner SM. Inflammation and microalbuminuria in non diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int 2000; 58: 1703-1710.

45.

Laviades C , Varo N , Diez J. Transforming growth factor β in hyper-tensives with cardiorenal damage. Hypertension 2000; 36: 517-522.

46.

Mennen LI , Balkau B , Royer B et al. Microalbuminuria and markers of the atherosclerotic process: the D.E.S.I.R. study. Atherosclerosis 2001; 154: 163-169.

47.

De Caterina R , Basta G , Lazzerini G et al. Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 2646-2654.

48.

Davis TM , Suputtamongkol Y , Spencer JL et al. Measures of capillary permeability in acute falciparum malaria: relation to severity of infection and treatment. Clin Infect Dis 1992; 15: 256-266.

49.

Hansen JM , Olsen NV , Feldt-Rasmussen B et al. Albuminuria and overall capillary permeability of albumin in acute altitude hypoxia. J Appl Physiol 1994; 76: 1922-1927.

50.

Pedrinelli R , Penno G , Dell’Omo G et al. Microalbuminuria and transvascular albumin leakage in essential hypertension. Hypertension 1999; 34: 491-495.

51.

Pedrinelli R , Penno G , Dell’Omo G et al. Transvascular and urinary leakage of albumin in atherosclerotic and hypertensive men. Hypertension 1998; 32: 312-318.

52.

Gruden G , Bruno A , Estivi P , Ferrero R , Fagano G , Cavallo-Perin P. Albumin excretion rate is not increased in atherosclerotic patients with vascular disease. Eur Rev Med Pharmacol Sci 1991; 13: 121-125.

53.

Haaber AB , Eidemark I , Jensen T , Feldt-Rasmussen B , Strandgaard S. Vascular endothelial cell function and cardiovascular risk factors in patients with chronic renal failure. J Am Soc Nephrol 1995; 5: 1581-1584.

54.

Jensen JS. Renal and systemic transvascular albumin leakage in severe atherosclerosis. Arterioscler Thromb Vasc Biol 1995; 15: 1324-1329.

55.

Jensen JS , Borch-Johnsen K , Jensen G , Feldt-Rasmussen B. Micro-albuminuria reflects a generalized transvascular albumin leakiness in clinically healthy subjects. Clin Sci (Colch) 1995; 88: 629-633.

56.

Yudkin JS , Forrest RD , Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 1988; ii: 530-533.

57.

Gould MM , Mohamed-Ali V , Goubet SA , Yudkin JS , Haines AP. Associations of urinary albumin excretion rate with vascular disease in europid nondiabetic subjects. J Diabetes Complications 1994; 8: 180-188.

58.

Haffner SM , Stern MP , Gruber MK , Hazuda HP , Mitchell BD , Patterson JK.

Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects?

Arteriosclerosis 1990; 10: 727-731.

59.

Jensen JS , Borch-Johnsen K , Feldt-Rasmussen B , Appleyard M , Jensen G. Urinary albumin excretion and history of acute myocardial infarction in a cross-sectional population study of 2,613 individuals. J Cardiovasc Risk 1997; 4: 121-125.

60.

Winocour PH , Harland JOE , Millar JP , Laker MF , Alberti KGMM: Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis 1992; 93:71-81.

61.

Diercks GF , van Boven AJ , Hillege HL et al. Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study. Eur Heart J 2000; 21: 1922-1927.

62.

Gerstein HC , Mann JF , Pogue J et al. Prevalence and determinants of microalbuminuria in high-risk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabetes Care 2000; 23 (suppl 2): B35-B39.

63.

Howard BV , Lee ET , Cowan LD et al. Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study. Am J Epidemiol 1995; 142: 254-268.

64.

Fabsitz RR , Sidawy AN , Go O et al. Prevalence of peripheral arterial disease and associated risk factors in American Indians: the Strong Heart Study. Am J Epidemiol 1999; 149: 330-338.

65.

Howard BV , Lee ET , Cowan LD et al. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation 1999; 99: 2389-2395.

66.

Kuusisto J , Mykkanen L , Pyorala K , Laakso M. Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease. Circulation 1995; 91: 831-837.

67.

Mykkanen L , Haffner SM , Kuusisto J , Pyorala K , Laakso M. Micro-albuminuria precedes the development of NIDDM. Diabetes 1994; 43: 552-557.

68.

Metcalf PA , Scragg RKR. Epidemiology of microalbuminuria in the general population. J Diabetes Complications 1994; 8: 157-163.

69.

Gorgels WJ , van der Graaf Y , Hjemdahl P et al. Urinary excretions of high molecular weight beta-thromboglobulin and albumin are independently associated with coronary heart disease in women, a nested case-control study of middle-aged women in the Diagnostisch Onderzoek Mammacarcinoom (DOM) Cohort, Utrecht, Netherlands. Am J Epidemiol 1995; 142: 1157-1164.

70.

Damsgaard EM , Froland A , Jorgensen OD , Mogensen CE. Micro-albuminuria as predictor of increased mortality in elderly people. BMJ 1990; 300: 297-300.

71.

Damsgaard EM , Froland A , Jorgensen OD , Mogensen CE. Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int 1992; 41: 731-735.

72.

Damsgaard EM , Froland A , Jorgensen OD , Morgensen CE. Prognostic value of urinary albumin excretion rate and other risk factors in elderly diabetic patients and non-diabetic control subjects surviving the first 5 years after assessment. Diabetologia 1993; 36: 1030-1036.

73.

Borch-Johnsen K , Feldt-Rasmussen B , Strandgaard S , Schroll M , Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19: 1992-1997.

74.

Jager A , Kostense PJ , Ruhe HG et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 617-624.

75.

Roest M , Banga JD , Janssen WM et al. Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation 2001; 103: 3057-3061.

76.

Gerstein HC , Mann JF , Yi Q et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 25: 421-426.

77.

Ljungman S , Wikstrand J , Hartford M , Berglund G. Urinary albumin excretion - a predictor of risk of cardiovascular disease. A prospective 10-year follow-up of middle-aged nondiabetic normal and hypertensive men. Am J Hypertens 1996; 9: 770-778.

78.

Agewall S , Wikstrand J , Ljungman S , Fagerberg B. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group. Am J Cardiol 1997; 80: 164-169.

79.

Agrawal B , Berger A , Wolf K , Luft FC. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension. J Hypertens 1996; 14: 223-228.

80.

Pontremoli R , Sofia A , Ravera M et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension: the MAGIC Study. Microalbuminuria: A Genoa Investigation on Complications. Hyper-tension 1997; 30: 1135-1143.

81.

Palatini P , Mormino P , Santonastaso M et al. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension: results from the HARVEST study. Hypertension 1998; 31:57-63.

82.

Jensen JS , Feldt-Rasmussen B , Borch-Johnsen K , Clausen P , Apple-yard M , Jensen G. Microalbuminuria and its relation to cardiovascular disease and risk factors. A population-based study of 1254 hypertensive individuals. J Hum Hypertens 1997; 11: 727-732.

83.

Bigazzi R , Bianchi S , Baldari D , Campese VM. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertens 1998; 16: 1325-1333.

84.

Jensen JS , Feldt-Rasmussen B , Strandgaard S , Schroll M , Borch-Johnsen K. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 2000; 35: 898-903.

85.

Janssen WM , Hillege H , Pinto-Sietsma SJ , Bak AA , De Zeeuw D , de Jong PE. Low levels of urinary albumin excretion are associated with cardiovascular risk factors in the general population. PREVEND Study Group. Prevention of REnal and Vascular ENd-stage Disease. Clin Chem Lab Med 2000; 38: 1107-1110.

86.

Poulsen PL , Ebbehoj E , Hansen KW , Mogensen CE. High normoor low microalbuminuria: basis for intervention in insulin-dependent diabetes mellitus. Kidney Int 1997; 63: S15-S18.

87.

O’Leary DH , Polak JF , Kronmal RA , Manolio TA , Burke GL , Wolf-son SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22.

88.

Ebrahim S. Use of B mode ultrasound of peripheral arteries as an end point in clinical trials. Br Heart J 1994; 72: 501-503.

89.

Agewall S , Wikstrand J , Ljungman S , Fagerberg B. Urinary albumin excretion is associated with the intima-media thickness of the carotid artery in hypertensive males with non-insulin-dependent diabetes mellitus. J Hypertens 1995; 13: 463-469.

90.

Pedrinelli R , Dell’Omo G , Penno G et al. Dissociation between micro-albuminuria and common carotid thickness in essential hypertensive men. J Hum Hypertens 2000; 14: 831-836.

91.

Bigazzi R , Bianchi S , Nenci R , Baldari D , Baldari G , Campese VM. Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens 1995; 9: 827-833.

92.

Pontremoli R , Nicolella C , Viazzi F et al. Microalbuminuria is an early marker of target organ damage in essential hypertension. Am J Hypertens 1998; 11: 430-438.

93.

Mykkanen L , Zaccaro DJ , O’Leary DH , Howard G , Robbins DC , Haffner SM. Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The insulin resistance atherosclerosis study (IRAS). Stroke 1997; 28: 1710-1716.

94.

Diercks GF , Janssen WM , van Boven AJ et al. Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria. Am J Cardiol 2000; 86: 635-638.